Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.
dc.contributor.author | Zeitler, Emily P | |
dc.contributor.author | Li, Yanhong | |
dc.contributor.author | Silverstein, Adam P | |
dc.contributor.author | Russo, Andrea M | |
dc.contributor.author | Poole, Jeanne E | |
dc.contributor.author | Daniels, Melanie R | |
dc.contributor.author | Al-Khalidi, Hussein R | |
dc.contributor.author | Lee, Kerry L | |
dc.contributor.author | Bahnson, Tristram D | |
dc.contributor.author | Anstrom, Kevin J | |
dc.contributor.author | Packer, Douglas L | |
dc.contributor.author | Mark, Daniel B | |
dc.contributor.author | CABANA Investigators | |
dc.date.accessioned | 2024-06-06T14:46:35Z | |
dc.date.available | 2024-06-06T14:46:35Z | |
dc.date.issued | 2023-02 | |
dc.description.abstract | Background Women with atrial fibrillation (AF) demonstrate more AF-related symptoms and worse quality of life (QOL). Whether increased use of ablation in women reduces sex-related QOL differences is unknown. Sex-related outcomes for ablation versus drug therapy was a prespecified analysis in the CABANA (Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation) trial. Methods and Results Symptoms were assessed periodically over 60 months with the Mayo AF-Specific Symptom Inventory (MAFSI) frequency score, and QOL was assessed with the Atrial Fibrillation Effect on Quality of Life (AFEQT) summary and component scores. Women had lower baseline QOL scores than men (mean AFEQT scores 55.9 and 65.6, respectively). Ablation patients improved more than drug therapy patients with similar treatment effect by sex: AFEQT 12-month mean adjusted treatment difference in women 6.1 points (95% CI, 3.5-8.6) and men 4.9 points (95% CI, 3.0-6.9). Participants with baseline AFEQT summary scores <70 had greater QOL improvement, with a mean treatment difference at 12 months of 7.6 points for women (95% CI, 4.3-10.9) and 6.4 points for men (95% CI, 3.3-9.4). The mean adjusted difference in MAFSI frequency score between women randomized to ablation versus drug therapy at 12 months was -2.5 (95% CI, -3.4 to -1.6); for men, the difference was -1.3 (95% CI, -2.0 to -0.6). Conclusions Compared with drug therapy for AF, ablation resulted in more QOL improvement in both sexes, primarily driven by improvements in those with lower baseline QOL. Ablation did not eliminate the AF-related QOL gap between women and men. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT00911508. | |
dc.identifier.issn | 2047-9980 | |
dc.identifier.issn | 2047-9980 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Ovid Technologies (Wolters Kluwer Health) | |
dc.relation.ispartof | Journal of the American Heart Association | |
dc.relation.isversionof | 10.1161/jaha.122.027871 | |
dc.rights.uri | ||
dc.subject | CABANA Investigators | |
dc.subject | Humans | |
dc.subject | Atrial Fibrillation | |
dc.subject | Anti-Arrhythmia Agents | |
dc.subject | Catheter Ablation | |
dc.subject | Treatment Outcome | |
dc.subject | Quality of Life | |
dc.subject | Female | |
dc.subject | Male | |
dc.subject | Surveys and Questionnaires | |
dc.title | Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial. | |
dc.type | Journal article | |
duke.contributor.orcid | Silverstein, Adam P|0000-0003-2013-5087 | |
duke.contributor.orcid | Al-Khalidi, Hussein R|0000-0003-1375-0487 | |
duke.contributor.orcid | Bahnson, Tristram D|0000-0001-9001-506X | |
duke.contributor.orcid | Mark, Daniel B|0000-0001-6340-8087 | |
pubs.begin-page | e027871 | |
pubs.issue | 3 | |
pubs.organisational-group | Duke | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Staff | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Biostatistics & Bioinformatics | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Cardiology | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Biostatistics & Bioinformatics, Division of Biostatistics | |
pubs.publication-status | Published | |
pubs.volume | 12 |
Files
Original bundle
- Name:
- 20230123_JAHA.122.027871.pdf
- Size:
- 1.03 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version